Delta opioid receptor agonists activate PI3K–mTORC1 signaling in parvalbumin-positive interneurons in mouse infralimbic prefrontal cortex to exert acute antidepressant-like effects
The delta opioid receptor (DOP) is a promising target for novel antidepressants due to its potential for rapid action with minimal adverse effects; however, the functional mechanism underlying acute antidepressant actions remains elusive. We report that subcutaneous injection of the selective DOP agonist KNT-127 reduced immobility in the forced swimming test, and that this antidepressant-like response was reversed by intracerebroventricular injection of the selective mechanistic (or mammalian) target of rapamycin (mTOR) inhibitor rapamycin or the phosphatidylinositol-3 kinase (PI3K) inhibitor LY294002. KNT-127 also alleviated social avoidance and reduced sucrose consumption (anhedonia) among chronic vicarious social defeat stress model mice, which were similarly reversed by PI3K and mTOR inhibitors. In addition, KNT-127 increased phosphorylation levels of the mTOR signaling-related proteins Akt and p70S6 kinase in medial prefrontal cortex as revealed by immunoblotting. In the forced swimming test, a microinfusion of KNT-127 and another DOP agonist SNC80 in the infralimbic prefrontal cortex (IL-PFC) attenuated the immobility, which were blocked by rapamycin and LY294002. Perfusion of KNT-127 onto IL-PFC slices increased miniature excitatory postsynaptic current frequency and reduced miniature inhibitory postsynaptic current frequency in pyramidal neurons as measured by whole-cell patch-clamping, and both responses were reversed by rapamycin. Imaging of brain slices from transgenic mice with DOP-promoter-driven green fluorescent protein revealed that most DOPs were expressed in parvalbumin-positive interneurons in the IL-PFC. These findings suggest that DOP agonists exert antidepressant-like actions by suppressing GABA release from parvalbumin-positive interneurons via the PI3K-Akt-mTORC1-p70S6 kinase pathway, thereby enhancing IL-PFC pyramidal neuron excitation.
Authors
- Akari Hagiwara (ORCID: https://orcid.org/0000-0001-6470-6641)
- Akiyoshi Saitoh (ORCID: https://orcid.org/0000-0001-8617-2441)
- Keita Iio (ORCID: https://orcid.org/0000-0001-9015-3585)
- Daisuke Yamada (ORCID: https://orcid.org/0000-0002-6989-6736)
- Tsuyoshi Saitoh (ORCID: https://orcid.org/0000-0001-6105-6292)
- Hiroshi Nagase
- Toshinori Yoshioka
- Keita Kajino
Institutions
- University of Tsukuba (JP)
- Tokyo University of Science (JP)
- Tsukuba International University (JP)
Publication Details
- Journal
- Molecular Psychiatry
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1038/s41380-024-02814-z
- Citations
- 6
- Primary Topic
- Tryptophan and brain disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- Japan Agency for Medical Research and Development